Cite
AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.
MLA
Amore, Giulia, et al. “AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.” American Journal of Ophthalmology, vol. 262, June 2024, pp. 114–24. EBSCOhost, https://doi.org/10.1016/j.ajo.2024.01.011.
APA
Amore, G., Romagnoli, M., Carbonelli, M., Cascavilla, M. L., De Negri, A. M., Carta, A., Parisi, V., Di Renzo, A., Schiavi, C., Lenzetti, C., Zenesini, C., Ormanbekova, D., Palombo, F., Fiorini, C., Caporali, L., Carelli, V., Barboni, P., & La Morgia, C. (2024). AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients. American Journal of Ophthalmology, 262, 114–124. https://doi.org/10.1016/j.ajo.2024.01.011
Chicago
Amore, Giulia, Martina Romagnoli, Michele Carbonelli, Maria Lucia Cascavilla, Anna Maria De Negri, Arturo Carta, Vincenzo Parisi, et al. 2024. “AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.” American Journal of Ophthalmology 262 (June): 114–24. doi:10.1016/j.ajo.2024.01.011.